Two Sigma Investments, LP Immunity Bio, Inc. Transaction History
Two Sigma Investments, LP
- $59 Billion
- Q3 2025
A detailed history of Two Sigma Investments, LP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 2,607,860 shares of IBRX stock, worth $5.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,607,860
Previous 802,563
224.94%
Holding current value
$5.42 Million
Previous $2.12 Million
202.88%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
297Shares Held
137MCall Options Held
2.59MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA27.7MShares$57.5 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$26.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$23.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$23.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.89MShares$14.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $833M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...